WallStreetZenWallStreetZen

NASDAQ: VTGN
Vistagen Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for VTGN

Based on 1 analyst offering 12 month price targets for Vistagen Therapeutics Inc.
Min Forecast
$30.00+469.26%
Avg Forecast
$30.00+469.26%
Max Forecast
$30.00+469.26%

Should I buy or sell VTGN stock?

Based on 1 analyst offering ratings for Vistagen Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VTGN stock forecasts and price targets.

VTGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Maxim Group
Bottom 2%
2
Strong BuyMaintains$30.00+469.26%2023-09-05

1 of 1

Forecast return on equity

Is VTGN forecast to generate an efficient return?
Company
-1,763.58%
Industry
31.53%
Market
58.17%
VTGN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VTGN forecast to generate an efficient return on assets?
Company
-803.52%
Industry
12.26%
VTGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VTGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VTGN$5.27$30.00+469.26%Strong Buy
RZLT$1.36$9.00+561.76%Strong Buy
OKYO$1.90N/AN/A
SLDB$2.50$5.00+100.00%Strong Buy
SLGL$1.81$9.50+425.44%Strong Buy
View Top Biotech Stocks

Vistagen Therapeutics Stock Forecast FAQ

Is Vistagen Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: VTGN) stock is to Strong Buy VTGN stock.

Out of 1 analyst, 1 (100%) are recommending VTGN as a Strong Buy, 0 (0%) are recommending VTGN as a Buy, 0 (0%) are recommending VTGN as a Hold, 0 (0%) are recommending VTGN as a Sell, and 0 (0%) are recommending VTGN as a Strong Sell.

If you're new to stock investing, here's how to buy Vistagen Therapeutics stock.

What is VTGN's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: VTGN) forecast ROE is -1,763.58%, which is considered weak.

What is VTGN's Price Target?

According to 1 Wall Street analyst that have issued a 1 year VTGN price target, the average VTGN price target is $30.00, with the highest VTGN stock price forecast at $30.00 and the lowest VTGN stock price forecast at $30.00.

The Wall Street analyst predicted that Vistagen Therapeutics's share price could reach $30.00 by Sep 5, 2024. The average Vistagen Therapeutics stock price prediction forecasts a potential upside of 469.26% from the current VTGN share price of $5.27.

What is VTGN's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: VTGN) forecast ROA is -803.52%, which is lower than the forecast US Biotechnology industry average of 12.26%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.